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Abstract
Malignant  eccrine  spiradenomas  are  exceedingly  rare  tu-
mours. They are aggressive tumours normally arising in long-stand-
ing benign eccrine spiradenomas. We present a case of malignant 
eccrine spiradenoma of the right side of the face with direct intra-
cranial extension without distant metastasis. A 48 years old woman 
presented with a large exophytic tumour on the right side of her 
face. Radiological imaging of the head and neck region revealed 
extensive invasion of the facial tissues around right orbit, maxilla 
and extension into the middle cranial fossa involving the right tem-
poral lobe. She underwent craniotomy and debulking of the right 
temporal lobe and biopsy of the facial tumour. Histopathological 
findings were consistent with malignant eccrine spiradenoma. This 
is a rare case of facial malignant eccrine spiradenoma with direct 
intracranial extension with no distant metastasis. A literature search 
revealed that it is first case to be reported of this kind.
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Introduction
  Eccrine spiradenoma is a benign sweat gland tumor that 
commonly affects young adults. The presentation is often a 
single nodule that may or may not be tender. In contrast, the 
malignant eccrine spiradenoma (MES) is an extremely rare 
tumor, which almost always arises from a pre-existing ec-
crine spiradenoma. The overall prognosis of malignant ec-
crine spiradenoma is poor [1].Our case report describes one 
such aggressive presentation of MES with direct intracranial 
extension without distant metastasis.
 
Case Report
  A 48 years old lady presented to the emergency depart-
ment with a large exophytic right-sided facial swelling. She 
was confused at the time of presentation and examination 
revealed right-sided facial palsy and chemosis of the right 
eye. Eye movements and pupillary reactions were normal. 
Upper and lower limb tone, power, sensation and reflexes 
were  grossly  normal.  The  patient  had  an  emergency  CT 
head which demonstrated a large enhancing tumour with ne-
crotic  areas  involving  the  right  half  of  face  especial-
ly along the right parotid, right infra temporal fossa, right pe-
trous temporal bone, right orbital and maxillary region. The 
mass extended intra cranially, displacing the right tempo-
ral lobe supero-medially causing surrounding brain oedema, 
left ventricular dilatation and about 1.3 cm of midline shift 
Manuscript accepted for publication June 24,  2009
aENT, Calderdale Royal Hospital, Halifax, United Kingdom, HX3 0PW
bRadiology, Calderdale Royal Hospital, Halifax, United Kingdom, HX3 
0PW
cCorresponding author: pbs6vas@yahoo.com
doi:10.4021/jocmr2009.07.1249
Figure 1. Axial CT scan image showing tumour invading the orbit, 
right side of skull base and destroying the bones. This is sugges-
tive of aggressive tumour.
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(Fig. 1). While awaiting fine needle aspiration and further 
imaging, her consciousness deteriorated further and she was 
transferred to the care of neurosurgeons. She had emergency 
craniotomy and debulking of right temporal tumour.
Post-operatively,  she  remained  neurologi-
cally  stable.  An  MRI  scan  of  the  head  and  neck 
region  demonstrated  a  large  soft  tissue  mass 
measuring 10 x 5 cm within the right side of the face ex-
tending  infero-temporally  into  the  middle  cranial  fos-
sa  with  necrotic  areas  (Fig.  2).  The  mass  was  found  to 
be very aggressive and invaded nearby soft tissues, mus-
cles and bones of the orbit,skull base, right ear, right tem-
poromandibular joint, right maxillary sinus, right carotid ar-
tery, right jugular vein, right temporal lobe causing cerebral 
oedema, midline shift and obstructive hydrocephalus.   Ab-
normal  enhancing  enlarged  lymph  nodes  are  noted  with-
in the right upper neck particularly level I and II.
Following further assessment, it was decided that the 
facial lesion was not amenable to curative surgery. Histol-
ogy of the debulked tumour has shown a malignant eccrine 
spiradenoma that is histologically highly malignant.
Her  case  was  discussed  at  the  regional  multidisci-
plinary team meeting, where it was decided that she was not 
a candidate for further surgery or chemo radiotherapy. She 
was transferred to the palliative care team and died 5 weeks 
after the diagnosis.
Discussion
  
Malignant  eccrine  spiradinoma  (MES)  is  a  rare  ad-
nexal carcinoma of the skin. It is normally considered to be 
a malignant transformation of a pre-existing benign eccrine 
spriradenoma [1-3]. MES presents at an average age of 59 
years (range: 21-92 years) and shows no sex predilection [4]. 
It tends to preferentially involve the trunk and extremities 
(92% of reported cases) [4], but there are also published case 
reports of MES arising in the breast  [4], scalp [5, 6], and 
eyelids [7, 8]. MES has been reported to occur on a trau-
matized area [9]. Literature review revealed only about 18 
reported cases involving the head and neck region [1, 10]. 
Overall prognosis of malignant eccrine spiradenoma is poor 
[1]. 
Primary  treatment  includes  local  excision,  with  or 
without regional lymphadenectomy [1], with recurrence re-
ported in 17.5% of the cases [4]. Malignant eccrine spirad-
enoma metastasizes to regional lymph nodes [3], lungs [11] 
, brain, skin [1] , bone [1]  and liver [4] (in descending order 
of frequency). Distant metastases of MES are uncommon 
even in extensive tumours, such as the one reported here, 
metastasis are rare but carry a poor prognosis  [4]. Radiation 
therapy alone or in combination with chemotherapy has been 
used with no benefit in the treatment of patients with meta-
static MES [4]. Sridhar et al reported symptomatic improve-
ment and shrinkage of the tumor with tamoxifen therapy in 
a patient with estrogen receptor-positive eccrine adenocarci-
noma [12]. However, the role of hormonal therapy still re-
mains to be determined. Close follow-up of these patients 
for early detection of recurrence and metastases cannot be 
overemphasized. 
We  report  the  first  case  of  malignant  eccrine  spi-
radenoma  of  the  face  extending  infero-temporal-
ly into the middle cranial fossa and involving right tem-
poral  lobe. This  tumour  was  locally  aggressive,  invading 
bones  of  the  orbit,  skull  base,  right  ear,  right  temporo-
mandibular  joint,  right  maxillary  sinus,  right  carotid  ar-
tery, right jugular vein and surrounding soft tissues, but had 
not metastasised to distant sites.
This case report describes one such aggressive presen-
tation of malignant eccrine spiradenoma with intracranial ex-
tension with no distant metastasis that unfortunately resulted 
in the patient’s death 5 weeks after the initial diagnosis.
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